Brief: Heat Biologics Announces Publication Of Additional Preclinical Covid-19 Vaccine Results
27/01/2021 12:59
Jan 27 (Reuters) - Heat Biologics Inc HTBX.O :
* HEAT BIOLOGICS ANNOUNCES PUBLICATION OF ADDITIONAL
PRECLINICAL
COVID-19 VACCINE RESULTS
* HEAT BIOLOGICS INC - SPIKE SPECIFIC CD8+ AND CD4+ T-CELL
MEMORY
RESPONSES OBSERVED 30- AND 60- DAYS POST VACCINATION
Source text for Eikon: [ID:https://bit.ly/3t0cSJ4]
Further company coverage: HTBX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Scorpius Holdings
See all newsBrief: Scorpius Holdings Inc Files For Non Timely 10-K With U.S. SEC
Brief: Scorpius Holdings Files For Offering Up To 29.4 Million Shares Of Common Stock
Brief: Scorpius Holdings Announces Collaboration With Celltheon Corporation
Brief: Scorpius Holdings - Implementation Of Strategic Cost-Saving Measures Expected To Save Over $2 Mln Annually
Brief: Scorpius Holdings Announces Partnership With U.S. Biotech Company